The DOI matches its Crossref record; 211 of the 216 references it cites were found in a registry or an index.
Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum
Open accessAbstract
Sporadic cerebral amyloid angiopathy (CAA) is a common age related cerebral small vessel disease, characterised by progressive deposition of amyloid-β (Aβ) in the wall of small to medium sized arteries, arterioles and capillaries of the cerebral cortex and overlying leptomeninges. Previously considered to be a rare neurological curiosity, CAA is now recognised as an important cause of spontaneous intracerebral haemorrhage and cognitive impairment in the elderly, two fundamental challenges in the field of cerebrovascular disease. Our understanding of the pathophysiology and clinical manifestations of CAA continues to evolve rapidly, with the use of transgenic mouse models and advanced structural and/or molecular neuroimaging techniques. Yet, despite remarkable recent interest, CAA remains under-recognised by neurologists and stroke physicians. In this review, a fresh look at key developments in understanding the complex pathophysiology, important clinical and radiological features, diagnostic approaches and prospects for rational therapies for this enigmatic small vessel disorder is provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although inherited forms of CAA have been described, CAA is most prevalent in AD, being present in over 90% of cases (Attems et al., 2011; Charidimou et al., 2012).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Charidimou et al., 2012
In the citing paper
“The ApoE4 allele is associated with increased risk of CAA, whereas both ApoE2 and 4 increase the risk of lobar hemorrhages (Charidimou et al., 2012).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Charidimou et al., 2012
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405 · cited 2×
“pathogenesis Ab deposition has complex effects on vascular structure and function which can result in brain injury.(32) 99 Important morphological changes include: loss of smooth muscle cells(100); vessel wall thickening and lumen restriction(67); endothelial dysfunction; and a loss of compliance leading to brittle, f…”
BackgroundHigh-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328 · cited 1×
“Leukoaraiosis appears as low attenuation on CT scans or hyperintensity on T2 weighted or FLAIR MRI, typically sparing subcortical U fibres (figure 4C).(147) Pathological substrates include demyelination, axon loss and mild gliosis.”
BackgroundNeurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836 · cited 1×
“There are three major polymorphisms in the ApoE genednamely, 34, 32 and 33dresulting in a single amino acid change(40) which dramatically alters the functional properties of ApoE isoforms.(41) These alleles have a strong dose dependent effect on the risk of developing CAA and its clinical severity.”
BackgroundCerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
“…of the circle of Willis and its branches, leukoaraiosis, and lacunar infarcts, microbleeds, microinfarcts, and CAA (Benedictus et al., 2013; Charidimou et al., 2012; Honig et al., 2005; Jellinger, 2013; Richardson et al., 2012; Roher et al., 2004; Toledo et al., 2013; Yarchoan et al.,…”
InfluentialEpidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
An, S. J., Kim, T. J., & Yoon, B.-W. (2017) · Journal of Stroke · doi:10.5853/jos.2016.00864 · Cited by 1,003
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647
Emerging concepts in sporadic cerebral amyloid angiopathy
Charidimou, A., Boulouis, G., Gurol, M. E., Ayata, C., Bacskai, B. J., Frosch, M. P., Viswanathan, A., & Greenberg, S. M. (2017) · Brain · doi:10.1093/brain/awx047 · Cited by 555
“…relevant manifestation of the disease: (i) it is a trigger of transient focal neurological symptoms (‘amyloid spells’) (Greenberg et al., 1993; Charidimou et al., 2012b), expanding the CAA clinical imaging spectrum (Raposo et al., 2011; Calviere et al., 2016); (ii) it has been shown to…”
BackgroundInfluentialSelf-citationThe neuropathology and cerebrovascular mechanisms of dementia
Raz, L., Knoefel, J., & Bhaskar, K. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 470
Metadata
- Authors
- Charidimou, A., Gang, Q., & Werring, D. J.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- Corresponding author
- Werring, David J
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2011-11-05
- Volume
- 83
- Issue
- 2
- Pages
- 124-137
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2148035614
- Cited by
- 611
- References
- 216
- Citations by year
- 2026: 19 · 2025: 25 · 2024: 22 · 2023: 30 · 2022: 46 · 2021: 37 · 2020: 79 · 2019: 43 · 2018: 68 · 2017: 46 · 2016: 53 · 2015: 46 · 2014: 39 · 2013: 42 · 2012: 14
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Stroke Association
- University College London Hospitals NHS Foundation Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- sporadic cerebral amyloid angiopathy, amyloid-beta deposition, cerebral small vessel disease, intracerebral hemorrhage, cognitive impairment, pathophysiology, clinical spectrum, neuroimaging, transgenic mouse model, diagnosis, treatment
- MeSH terms
- Aged, Alzheimer Disease, Animals, Cognition Disorders, Dementia, Hemorrhage, Humans, Magnetic Resonance Imaging, Risk Factors, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. https://app.cochat.ai/papers/10.1136/jnnp-2011-301308
- The paper
- Charidimou, A., Gang, Q., & Werring, D. J. (2012). Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2011-301308
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.